🔗 Share this article

Acclaimed soul vocalist D’Angelo died on October 14 at age 51 after a personal fight with pancreatic malignancy.

“The brilliant light of our household has dimmed his light for us in this life,” his relatives stated. “After a prolonged and brave battle with cancer, we are heartbroken to declare that Michael D’Angelo Archer, recognized by his followers around the world as D’Angelo, has been called home.”

D’Angelo made a lasting impact on music with his innovative neo-soul sound and collaborations with renowned musicians.

He launched his debut album, “Brown Sugar,” in the mid-nineties to instant praise. The album achieved the fourth spot on Billboard’s Top R&B Albums chart, went platinum soon after, and received several Grammy nominations.

However, it was his sophomore release, “Voodoo,” in 2000 that boosted his artistic journey into the limelight. The record debuted at No. 1 on both the R&B charts and the Billboard 200. He won two Grammy Awards: Top R&B Record and Best Male R&B Vocal Performance for “Untitled (How Does It Feel).”

The visual for “Untitled (How Does It Feel)” solidified D’Angelo’s standing as a sex symbol, albeit a reluctant one, in the cultural zeitgeist. The personal depiction featured the singer, notably bare to his midsection, singing directly into the lens.

D’Angelo stepped back from the spotlight after releasing Voodoo and openly battled with drugs and alcohol. In 2005, he was involved in a serious car crash that put him in critical condition.

Over ten years later, his last record, “Black Messiah” (2014), confirmed his enduring appeal with a further No. 1 debut on the soul music rankings and a award for Top R&B Record.

Again, in his own enigmatic fashion, D’Angelo had limited public appearances in the following years.

The musician was announced as a headliner for the 2025 Roots Picnic festival, but his performance was canceled, citing an “unforeseen medical delay.”

Although details are sparse about D’Angelo’s well-being in the months before his passing, he had apparently been in the hospital for an extended period and in palliative care for two weeks.

D’Angelo’s demise is a clear example of the harmful impact of pancreatic cancer, one of the deadliest and least preventable forms of the disease, on a brilliant talent whose life was cut short.

“We are saddened that he can only provide dear memories with his loved ones, but we are forever thankful for the legacy of extraordinarily moving music he has left us,” his kin expressed.

Pancreatic Malignancy: Deadly and Rarely Preventable

Pancreatic cancer impacts the pancreas, a tiny gland that generates the hormone insulin and plays an essential role in digestion, among additional roles. The size and location of the pancreas in the body make it more challenging to identify cancer.

Even though this cancer accounts for only approximately three percent of malignancy cases each year in the U.S., it is responsible for seven percent of malignancy fatalities.

Nearly 70,000 individuals will be diagnosed with pancreatic cancer and roughly fifty-two thousand will die of the illness in 2025.

“Pancreatic cancer is one of the deadliest cancers, with an fast-growing mass and dismal outcomes. We have few and poor therapies, and a smaller window to make a meaningful impact on the lives of people,” said a cancer specialist.

Since pancreatic cancer rarely causes initial signs, it’s frequently identified only after the condition is late-stage. Even when a patient has indicators they are usually nonspecific and may be mistaken for a number of everyday ailments.

“Currently, there is no good way to identify pancreatic cancer in the early stages, apart from paying attention to physical changes and speaking with your physician if there are new or unusual symptoms,” said a health expert.

Common symptoms of pancreatic cancer include:

• abdominal or lower back pain
• reduced body mass
• yellowing of skin and eyes
• loss of appetite
• brownish urine
• pale or fatty bowel movements
• loose stools
• excessive hunger or thirst
• nausea

At 51 years old, D’Angelo’s death is an outlier, as pancreatic cancer is most common in individuals in the 65 to 75 range. However, numerous malignancies, such as this type, have become increasingly prevalent in younger people.

“Pancreatic cancer diagnosed prior to fifty is considered rare, yet concerningly, clinicians are noticing a growing number of younger patients affected by this disease,” said a specialist.

Genetic Background Affects Disease Probability

In the absence of effective screening tools for pancreatic cancer, professionals emphasized the significance of knowing your family’s cancer history. Certain risk factors, such as smoking and excess weight also have an influence in the development of this disease.

Black individuals have the greatest occurrence of pancreatic cancer in the United States and are most likely to be found to have inoperable cancer.

“The first step toward lowering one’s chance of pancreatic cancer is understanding personal risk factors. People should review their genetic background, hereditary factors, and medical conditions, such as blood sugar disease, chronic pancreatitis, or overweight that may raise their vulnerability,” advised a specialist.

Hereditary risk factors are linked to as much as 10% of all this malignancy cases. If a relative in your household has had pancreatic cancer, you may want to think about DNA analysis.

“For individuals with a family history of this condition or those having high risk genetic mutations, screening may involve sophisticated scans such as magnetic resonance imaging (MRI) or endoscopic ultrasound (EUS) to find early changes in the organ,” he explained.

For those wishing to lower their chance, lifestyle changes may have an effect. The best step you can take to lower your risk of pancreatic cancer is to quit smoking, and if you don’t smoke, stay away altogether.

Heavy drinking is linked to pancreatitis, a contributing element for this malignancy, so reducing or abstaining from drinks may help reduce your risk.

Managing your weight or shedding pounds may also help reduce your risk. People with obesity are twenty percent more prone to develop this disease. This malignancy also occurs more often in people with blood sugar issues, and reducing weight can also lower the chance of type 2 diabetes.

Despite pancreatic cancer’s poor prognosis, there is reason for optimism.

“We are making progress with therapies and more recent combination chemotherapy. There are emerging targeted therapies that are already showing results,” said a specialist.

For many individuals, however, awareness about this uncommon but {dev